Vir Biotechnology to Present at 38th Annual J.P. Morgan Healthcare Conference

NEXT STORY
Basilea at the 38th Annual J. P. Morgan Healthcare Conference – significant progress in Cresemba commercialization and R&D portfolio in 2019
PREV STORY
Galera Therapeutics Announces Dosing of First Patient in Phase 2a Clinical Trial of Avasopasem Manganese (GC4419) in Second Indication
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

numares initiates pan-European multicenter study of AXINON® renalTX-SCORE® on kidney allograft rejection

PARASOL multicenter study to continue building clinical case for non-invasive renal allograft rejection testing ...

author_avatar
NASDAQ Market News

Kessler Foundation Study Explores Mindfulness-based Therapy in Children and Adolescents with Brain Injury

EAST HANOVER, N.J., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Kessler Foundation and Children's Specialized ...

author_avatar
NASDAQ Market News

Ziopharm Oncology Announces Changes to Board of Directors and Management Team

-- CEO Laurence Cooper Appointed to Board of Directors -- Francois Lebel to Depart Company BOSTON, ...

author_avatar
NASDAQ Market News